Skip to main content
Fig. 5 | Clinical Epigenetics

Fig. 5

From: Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers

Fig. 5

Association between the 5hLD-score and disease progression. A Boxplots showing the distribution of the 5hLD-score in cancer patients and patients with benign diseases. B Boxplots showing the association between the 5hLD-score and HCC progression. Statistical significance was determined using the Wilcoxon rank-sum test. CC, colon cancer; CHB, chronic hepatitis B virus infection; GC, gastric cancer; HCC, hepatocellular carcinoma; 5hLD-score, 5hmC-LncRNA diagnostic score; LC, liver cirrhosis

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us